Tuesday, September 15, 2026

AI vs. Human Skills: Are Doctors Losing Their Edge After AI Use?

A study shows that physicians' skills may decline after stopping AI use, highlighting the need for careful assessment of AI's impact on human capabilities.

AI Girlfriends That Never Say No: The Future of ‘Guilt-Free’ Affairs?

LOVERSE, an AI dating app, offers guilt-free romance for married users but faces criticism for its lack of authenticity and emotional depth.

Trump Open to Unconditional Talks with Kim Jong Un: What Does This Mean for U.S.-North Korea Relations?

Trump is open to unconditional talks with Kim, emphasizing past summits while maintaining U.S. policy towards North Korea.

Health

Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra

Celltrion has submitted a U.S. Phase 4 trial application to support the use of a higher 240 mg dose of Zymfentra, aiming to expand personalized dosing options and strengthen the drug's position in the U.S. market.

Blood Proteins May Offer Clues to Alzheimer’s Antibody Treatment Benefits and Side-Effect Risks

A South Korean study found that blood levels of complement proteins C1q and C3 may help predict amyloid reduction and ARIA risk in patients receiving lecanemab, though larger studies are needed.

Pentrym Confirms Combination Benefits With Existing Cancer Drugs, Targets “False Resistance”

Pentrym is testing whether targeting the tumor microenvironment alongside existing cancer drugs can overcome “false resistance” and improve treatment effectiveness.

YH42946: The Promising HER2 Targeted Oral Treatment Set to Transform Cancer Care in 2026

Yuhan Corporation will reveal early results of its oral HER2-targeted therapy candidate 'YH42946' in clinical trials by year-end.

SK Biopharm Achieves MSCI ESG AAA Rating for 3rd Consecutive Year: What It Means for the Pharma Industry

SK Biopharm has achieved the highest AAA rating in MSCI's ESG evaluation for three consecutive years.
Latest

Unlocking UAE: How Korean Biotech Firms Can Navigate Regulatory Hurdles in 2026

The Ministry of Food and Drug Safety will facilitate communication between local regulatory authorities and Korean bio companies for UAE market entry.

Expanded 119 Emergency Call Service: How It Protects Vulnerable Residents in 2026

The 119 Safe Call service expands to include residents in flood-risk areas and children who struggle to evacuate during fires.

Unlocking the Future: South Korea’s 2031 BCI Research Plan with 300 Primates

The government plans to secure 300 primates for brain-computer interface research by 2031, focusing on safety and performance validation.

SK Biopharm’s Bold Move: How MD Expertise is Shaping Global Drug Development in 2026

SK Biopharm is enhancing its global competitiveness in drug development by establishing a specialized R&D system for new drug candidates.

Lunit to Present 3 Lung Cancer AI Studies at WCLC, Highlighting Potential for Precision Treatment

Lunit will present three studies using its AI biomarker platform Lunit SCOPE IO at WCLC 2026, focusing on links between genetic mutations, the tumor microenvironment and treatment response.

Humedics Targets Southeast Asian Aesthetic Market With Participation in Thai Medical Aesthetics Conference

Humedics showcased its hyaluronic acid filler Elravie Premier at ASLS Bangkok 2026 and highlighted clinical experience and treatment techniques to expand its presence in Thailand and Southeast Asia.

Dong-A ST’s ‘HiCardi’ Expands to 6 Asia-Pacific Countries as Overseas Push Accelerates

Dong-A ST will supply its wearable patient monitoring platform HiCardi to six Asia-Pacific countries through Schiller Asia Pacific.

“A New Era for Skin Treatments Has Arrived”: Wontech Unveils ‘Oligio XM’ for First Time

Wontech unveiled its new flagship Oligio XM, combining radiofrequency and high-intensity focused ultrasound technologies in a single device.

Cholera Vaccine Use Expands From Emergency Response to Prevention, Spotlighting EuBiologics’ Supply Role

As cholera vaccination expands from emergency campaigns in outbreak areas to preventive immunization, EuBiologics is playing a growing role in global oral cholera vaccine supply.

DeepNoid to Present 8 Medical AI Studies at KCR, Targeting Clinical Applications

DeepNoid will present eight studies on medical AI at KCR 2026, highlighting diagnostic assistance and image analysis performance in chest and brain imaging.

HLB Panagene Introduces PNA Technology at U.S. Conference, Seeks Global Partnerships

HLB Panagene introduced its peptide nucleic acid technology at a U.S. conference and discussed research and business collaboration opportunities with global pharmaceutical and biotech companies.

Mobicare: The Wearable AI ECG Solution Now Approved in Canada – What This Means for North America

The wearable AI ECG analysis solution MobiCare has received medical device approval in Canada, expanding its North American market presence.

HK inno.N’s K-CAB 50 mg Becomes World’s First to Earn EPD Certification, Demonstrating Environmental Credentials

HK Inno.N's K-CAB 50mg becomes the world's first oral medication to receive Environmental Product Declaration (EPD) certification.

Is Your Heart at Risk? New MRR Indicator Reveals Hidden Microvascular Issues

A study reveals a new indicator to identify patients with reduced coronary microvascular function, linked to higher cardiovascular disease risk.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.